Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (6)
  • Microtubule Associated
    (4)
  • EGFR
    (3)
  • Akt
    (2)
  • Tyrosine Kinases
    (2)
  • AChR
    (1)
  • Antiviral
    (1)
  • Autophagy
    (1)
  • CDK
    (1)
  • Others
    (63)
Filter
Search Result
Results for "

anti-tumour

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    91
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    7
    TargetMol | Natural_Products
  • Recombinant Protein
    6
    TargetMol | Recombinant_Protein
Sotorasib
AMG-510
T86842296729-00-3
Sotorasib (AMG-510) is an orally active and selective covalent inhibitor of KRAS G12C. Sotorasib binds to the GDP state of the inactive conformation of KRAS G12C and inhibits KRAS and its downstream signaling. Sotorasib exhibits inhibitory activity against KRAS G12C mutant tumors.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Gefitinib
ZD1839
T1181184475-35-2
Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations. Gefitinib has antitumor activity and is used for the treatment of EGFR-mutated non-small-cell lung cancers. Gefitinib administration RESULTS in the development of the EGFR C797S resistance mutation.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Estramustine phosphate sodium
Ro 21-8837 001, Estramustine phosphate disodium
T445152205-73-9
Estramustine phosphate sodium (Ro 21-8837 001) is an antimicrotubule chemotherapy agent; arrests prostate cancer cells in the G2 M phase of the cell cycle.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Erbulozole
R-55104, R55104, R 55104
T25384124784-31-2In house
Erbulozole (R 55104) is a potent synthetic microtubule inhibitor with anti-invasive, anti-tumor, and radiosensitizing activities that induces Wernicke's encephalopathy-like neurotoxicity.
  • Inquiry Price
6-8weeks
Size
QTY
Poloxin-2
Poloxin2, Poloxin 2
T25969321695-37-8In house
Poloxin-2 is a potent and selective Plk1 PBD inhibitor with anti-tumour activity that reduces the protein level of Plk1 in HeLa cells.
  • Inquiry Price
6-8 weeks
Size
QTY
BMS-960
BMS 960, BMS960
T268661265321-86-5In house
BMS-960 is an S1P agonist with potential anti-tumour activity for cancer research.
  • Inquiry Price
8-10 weeks
Size
QTY
Glutathione arsenoxide hydrochloride
GSAO HCl, Glutathione arsenoxide hydrochloride(1271726-51-2 Free base)
T27417L In house
Glutathione arsenoxide hydrochloride (Glutathione arsenoxide hydrochloride(1271726-51-2 Free base)) is a potentially active anti-cancer molecule and inhibitor of tumour metabolism. glutathione arsenoxide hydrochloride targets the mitochondrial inner membrane adenine nucleotidyl transferase (ANT), which inhibits cell proliferation and promotes apoptosis. Glutathione arsenoxide hydrochloride can be used to recognize cell surface proteins such as protein disulfide isomerases.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Tafetinib
SIM-010603, SIM010603, SIM 010603
T289111032265-57-8In house
Tafetinib (SIM-010603) is a novel potent and orally available tyrosine kinase inhibitor with anti-angiogenic and anti-tumour activity.
  • Inquiry Price
6-8weeks
Size
QTY
NM-3
Isocoumarin NM-3, NM3, NM 3
T33701181427-78-1In house
NM-3 is an orally available anti-angiogenic inhibitor with anti-tumour activity.NM-3 is used as a radiation modulator in vitro and in vivo.NM-3 inhibits vascular endothelial growth factor (VEGF), thereby inhibiting the proliferation of endothelial cells. This inhibits the proliferation of endothelial cells. NM-3 is associated with a mechanism of apoptosis induction by reactive oxygen species.
  • Inquiry Price
6-8weeks
Size
QTY
ihmt-trk-284
T630762416844-79-4In house
IHMT-TRK-284 (Compound 34) is a potent, orally active type II TRK kinase inhibitor with IC50 values of 10.5 nM for TRKA, 0.7 nM for TRKB, and 2.6 nM for TRKC. The compound demonstrates good selectivity within the kinase group and exhibits significant anti-tumor efficacy in vivo.
  • Inquiry Price
6-8 weeks
Size
QTY
ifebemtinib
IN-10018, BI-853520
T641671227948-82-4In house
Ifebemtinib (BI-853520) is an orally active and potent inhibitor of adhesion plaque kinase (FAK) (IC50=1 nM) with anti-tumour activity that inhibits globule formation and in situ tumour growth in malignant pleural mesotheliomas, and may be useful for the study of breast and ovarian cancer.
  • Inquiry Price
8-10 weeks
Size
QTY
ALK/ROS1 inhibitor 2e HCL
(R)-1-(2-((2-methoxy-4-(piperazin-1-yl)phenyl)amino)pyridin-4-yl)-N-(4-(trifluoromethoxy)benzyl)piperidine-3-carboxamide hydrochloride(2365497-12-5 Free base)
T67699L In house
ALK ROS1 inhibitor 2e HCL possesses anti-apoptotic, anti-proliferative and anti-tumour activities.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Talmetacin
T6815267489-39-8In house
Talmetacin has anti-inflammatory and analgesic and anti-tumour activity and can be used to study cardiovascular disease.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
(S)-OSMI 3
Ent-OSMI-3
T836462411972-78-4In house
(S)-OSMI 3 (Ent-OSMI-3) has anti-inflammatory and anti-tumour activity and can be used to study diabetes and neurodegenerative diseases.
  • Inquiry Price
Size
QTY
IMT1B
3-Piperidinecarboxylic acid, 1-[(2R)-2-[[4-(2-chloro-4-fluorophenyl)-2-oxo-2H-1-benzopyran-7-yl]oxy]-1-oxopropyl]-, (3S)-, LDC203974
T88422304621-06-3In house
IMT1B (LDC203974) is an orally administered, specific noncompetitive allosteric inhibitor of mitochondrial RNA polymerase (POLRMT), effectively suppressing mitochondrial DNA (mtDNA) expression and conferring anti-tumor properties.
  • Inquiry Price
Size
QTY
Esculetin
Cichorigenin, Aesculetin
T2798305-01-1
Esculetin (Cichorigenin) is a coumarin derivative from various natural plant products with various biological and pharmaceutical properties including anti-edema, anti-inflammatory and anti-tumour effects. It inhibits lipoxygenases (LOs).
  • Inquiry Price
Size
QTY
(-​)​-​α-​Terpineol
α-Terpineol
T746810482-56-1
(-)-α-Terpineol has antitumour, anti-inflammatory, and antimicrobial activities, it inhibits the growth of tumour cells through a mechanism that involves inhibition of the NF-kappaB pathway
  • Inquiry Price
Size
QTY
A-176120
T26469185049-54-1In house
A-176120 is a potent farnesyl pyrophosphate (FPP) analogues, it selectively inhibits farnesyltransferase. It has anti-angiogenic potential and may reduce H-ras NIH3T3 tumour growth.
  • Inquiry Price
1-2 weeks
Size
QTY
CC-885
T148931010100-07-8
CC-885 is a modulator of cereblon (CRBN). It has potent anti-tumour activity.
  • Inquiry Price
Size
QTY
JND3229
T156152260886-64-2
JND3229 is a reversible EGFRC797S inhibitor with IC50 values of 5.8, 6.8 and 30.5 nM for EGFRL858R T790M C797S, EGFRWT and EGFRL858R T790M, respectively. JND3229 has good anti-proliferative activity and can effectively inhibit tumour growth in vivo. JND3229 can be used in cancer research, especially in non-small cell carcinoma.
  • Inquiry Price
8-10 weeks
Size
QTY
Lobaplatin
D-19466
T15771135558-11-1
Lobaplatin (D-19466) (D-19466) is a diastereometric mixture of platinum(II) complexe. Lobaplatin (D-19466) is a third-generation platinum anti-neoplastic agent which shows activity for a variety of tumour types and is a promising antitumour chemotherapeutic agent[1][2]. It is a platinum complex with DNA alkylating activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
RX-3117
fluorocyclopentenylcytosine, TV-1360
T16813865838-26-2
RX-3117 (fluorocyclopentenylcytosine) is a novel a cytidine analog. RX-3117 displays anticancer activity in several cancer cell lines, including gemcitabine-resistant variants.
  • Inquiry Price
Size
QTY
LY 135114
LY135114,LY-135114
T27873126254-82-8
LY 135114 is a metabolite of LY 195448, which is a phenethanolamine with anti-tumour activity.
  • Inquiry Price
Size
QTY
LY195448 HCl
LY195448,UNII-BR0DFE3GF6,LY-195448
T27891111112-18-6
LY195448 HCl is a phenethanolamine shown anti-tumour activity. It blocks cells at metaphase.
  • Inquiry Price
1-2 weeks
Size
QTY